We describe the association of newly generated metabolic signatures with other well-known transcriptomics HCC subclasses (such as those of Hoshida [14], Chiang [15]) and with the presence of TP53 or CTNNB1 driver mutations. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.